Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 79

1.

Reduced-Toxicity (BuFlu) Conditioning Is Better Tolerated but Has a Higher Second Transplantation Rate Compared to Myeloablative Conditioning (BuCy) in Children with Inherited Metabolic Disorders.

Gupta A, Downey M, Shanley R, Jennissen C, Miller WP, Lund TC, Orchard PJ, Smith AR.

Biol Blood Marrow Transplant. 2019 Nov 18. pii: S1083-8791(19)30781-5. doi: 10.1016/j.bbmt.2019.11.014. [Epub ahead of print]

PMID:
31751770
2.

Surveillance Imaging after Autologous Hematopoietic Cell Transplantation Predicts Survival in Patients with Diffuse Large B Cell Lymphoma.

Savani M, Gencturk M, Shanley R, Cayci Z, Wilke C, Warlick ED, He F, Janakiram M, Weisdorf DJ, Brunstein CG, Bachanova V.

Biol Blood Marrow Transplant. 2019 Oct 24. pii: S1083-8791(19)30670-6. doi: 10.1016/j.bbmt.2019.10.013. [Epub ahead of print]

PMID:
31669174
3.

Post-transplant laronidase augmentation for children with Hurler syndrome: biochemical outcomes.

Lund TC, Miller WP, Liao AY, Tolar J, Shanley R, Pasquali M, Sando N, Bigger BW, Polgreen LE, Orchard PJ.

Sci Rep. 2019 Oct 1;9(1):14105. doi: 10.1038/s41598-019-50595-1.

4.

Emotional functioning among children with neurofibromatosis type 1 or Noonan syndrome.

McNeill AM, Hudock RL, Foy AMH, Shanley R, Semrud-Clikeman M, Pierpont ME, Berry SA, Sommer K, Moertel CL, Pierpont EI.

Am J Med Genet A. 2019 Dec;179(12):2433-2446. doi: 10.1002/ajmg.a.61361. Epub 2019 Sep 30.

PMID:
31566897
5.

Estimating survival in patients with gastrointestinal cancers and brain metastases: An update of the graded prognostic assessment for gastrointestinal cancers (GI-GPA).

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu JB, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney NA, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Clin Transl Radiat Oncol. 2019 Jun 27;18:39-45. doi: 10.1016/j.ctro.2019.06.007. eCollection 2019 Sep.

6.

Haptoglobin genotype and gut barrier-related complications of allogeneic hematopoietic cell transplantation.

Rashidi A, Allen T, Shanley R, Ebadi M, Weisdorf DJ.

Bone Marrow Transplant. 2019 May 8. doi: 10.1038/s41409-019-0540-2. [Epub ahead of print] No abstract available.

PMID:
31068658
7.

Red blood cell product utilization in patients undergoing allogeneic stem cell transplantation.

Gastecki K, Shanley R, Welbig J, Cohn C, Brunstein CG.

Transfusion. 2019 Jul;59(7):2301-2307. doi: 10.1111/trf.15285. Epub 2019 Apr 8.

PMID:
30957250
8.

Survival and prognostic factors in patients with gastrointestinal cancers and brain metastases: have we made progress?

Sperduto PW, Fang P, Li J, Breen W, Brown PD, Cagney D, Aizer A, Yu J, Chiang V, Jain S, Gaspar LE, Myrehaug S, Sahgal A, Braunstein S, Sneed P, Cameron B, Attia A, Molitoris J, Wu CC, Wang TJC, Lockney N, Beal K, Parkhurst J, Buatti JM, Shanley R, Lou E, Tandberg DD, Kirkpatrick JP, Shi D, Shih HA, Chuong M, Saito H, Aoyama H, Masucci L, Roberge D, Mehta MP.

Transl Res. 2019 Jun;208:63-72. doi: 10.1016/j.trsl.2019.02.011. Epub 2019 Feb 27.

PMID:
30885538
9.

Mixed vs full donor engraftment early after hematopoietic cell transplant: Impact on incidence and control of cytomegalovirus infection.

Green JS, Shanley RM, Brunstein CG, Young JH, Verneris MR.

Transpl Infect Dis. 2019 Jun;21(3):e13070. doi: 10.1111/tid.13070. Epub 2019 Mar 29.

PMID:
30864271
10.

Pretransplant Serum Citrulline Predicts Acute Graft-versus-Host Disease.

Rashidi A, Shanley R, Holtan SG, MacMillan ML, Blazar BR, Khoruts A, Weisdorf DJ.

Biol Blood Marrow Transplant. 2018 Nov;24(11):2190-2196. doi: 10.1016/j.bbmt.2018.06.036. Epub 2018 Jul 7.

11.

Estimating survival for renal cell carcinoma patients with brain metastases: an update of the Renal Graded Prognostic Assessment tool.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Neuro Oncol. 2018 Nov 12;20(12):1652-1660. doi: 10.1093/neuonc/noy099.

12.

Analysis of BMT CTN-0201 and -0901 samples did not reproduce the reported association between recipient REG3A rs7588571 and chronic GVHD.

Rashidi A, Shanley R, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ.

Bone Marrow Transplant. 2019 Mar;54(3):490-493. doi: 10.1038/s41409-018-0331-1. Epub 2018 Aug 31. No abstract available.

PMID:
30171221
13.

Core-binding factor acute myeloid leukemia with t(8;21): Risk factors and a novel scoring system (I-CBFit).

Ustun C, Morgan E, Moodie EEM, Pullarkat S, Yeung C, Broesby-Olsen S, Ohgami R, Kim Y, Sperr W, Vestergaard H, Chen D, Kluin PM, Dolan M, Mrózek K, Czuchlewski D, Horny HP, George TI, Kristensen TK, Ku NK, Yi CA, Møller MB, Marcucci G, Baughn L, Schiefer AI, Hilberink JR, Pullarkat V, Shanley R, Kohlschmidt J, Coulombe J, Salhotra A, Soma L, Cho C, Linden MA, Akin C, Gotlib J, Hoermann G, Hornick J, Nakamura R, Deeg J, Bloomfield CD, Weisdorf D, Litzow MR, Valent P, Huls G, Perales MA, Borthakur G.

Cancer Med. 2018 Sep;7(9):4447-4455. doi: 10.1002/cam4.1733. Epub 2018 Aug 16.

14.

Recipient single nucleotide polymorphisms in Paneth cell antimicrobial peptide genes and acute graft-versus-host disease: analysis of BMT CTN-0201 and -0901 samples.

Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Scott BL, Blazar BR, Weisdorf DJ.

Br J Haematol. 2018 Sep;182(6):887-894. doi: 10.1111/bjh.15492. Epub 2018 Jul 13.

15.

Effect of Targeted Therapies on Prognostic Factors, Patterns of Care, and Survival in Patients With Renal Cell Carcinoma and Brain Metastases.

Sperduto PW, Deegan BJ, Li J, Jethwa KR, Brown PD, Lockney N, Beal K, Rana NG, Attia A, Tseng CL, Sahgal A, Shanley R, Sperduto WA, Lou E, Zahra A, Buatti JM, Yu JB, Chiang V, Molitoris JK, Masucci L, Roberge D, Shi DD, Shih HA, Olson A, Kirkpatrick JP, Braunstein S, Sneed P, Mehta MP.

Int J Radiat Oncol Biol Phys. 2018 Jul 15;101(4):845-853. doi: 10.1016/j.ijrobp.2018.04.006. Epub 2018 Apr 12.

PMID:
29976497
16.

Failure rate in pediatric cochlear implantation and hearing results following revision surgery.

Gardner PA, Shanley R, Perry BP.

Int J Pediatr Otorhinolaryngol. 2018 Aug;111:13-15. doi: 10.1016/j.ijporl.2018.05.017. Epub 2018 May 24.

PMID:
29958596
17.

Social skills in children with RASopathies: a comparison of Noonan syndrome and neurofibromatosis type 1.

Pierpont EI, Hudock RL, Foy AM, Semrud-Clikeman M, Pierpont ME, Berry SA, Shanley R, Rubin N, Sommer K, Moertel CL.

J Neurodev Disord. 2018 Jun 18;10(1):21. doi: 10.1186/s11689-018-9239-8.

18.

Absence of early HHV-6 reactivation after cord blood allograft predicts powerful graft-versus-tumor effect.

Rashidi A, Ebadi M, Said B, Cao Q, Shanley R, Curtsinger J, Bejanyan N, Warlick ED, Green JS, Brunstein CG, Miller JS, Weisdorf DJ.

Am J Hematol. 2018 May 14. doi: 10.1002/ajh.25141. [Epub ahead of print]

19.

Combination of interferon-expressing oncolytic adenovirus with chemotherapy and radiation is highly synergistic in hamster model of pancreatic cancer.

Salzwedel AO, Han J, LaRocca CJ, Shanley R, Yamamoto M, Davydova J.

Oncotarget. 2018 Apr 6;9(26):18041-18052. doi: 10.18632/oncotarget.24710. eCollection 2018 Apr 6.

20.

Post-transplant adaptive function in childhood cerebral adrenoleukodystrophy.

Pierpont EI, McCoy E, King KE, Ziegler RS, Shanley R, Nascene D, Raymond GV, Phelan R, Lund TC, Orchard PJ, Miller WP.

Ann Clin Transl Neurol. 2018 Jan 22;5(3):252-261. doi: 10.1002/acn3.526. eCollection 2018 Mar.

21.

Association between recipient TNF rs361525 and acute GVHD: results from analysis of BMT CTN-0201 samples.

Rashidi A, Shanley R, Yohe SL, Thyagarajan B, Curtsinger J, Anasetti C, Waller EK, Miller JS, Blazar BR, Weisdorf DJ.

Bone Marrow Transplant. 2018 Aug;53(8):1069-1071. doi: 10.1038/s41409-018-0127-3. Epub 2018 Mar 7. No abstract available.

22.

Fewer Circulating Natural Killer Cells 28 Days After Double Cord Blood Transplantation Predicts Inferior Survival and IL-15 Response.

Bergerson RJ, Williams R, Wang H, Shanley R, Colbenson G, Kerber A, Cooley S, Curtsinger J, Felices M, Miller JS, Verneris MR.

Blood Adv. 2016 Dec 27;1(3):208-218. doi: 10.1182/bloodadvances.2016000158. Epub 2016 Oct 30.

23.

Estimating Survival in Melanoma Patients With Brain Metastases: An Update of the Graded Prognostic Assessment for Melanoma Using Molecular Markers (Melanoma-molGPA).

Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M.

Int J Radiat Oncol Biol Phys. 2017 Nov 15;99(4):812-816. doi: 10.1016/j.ijrobp.2017.06.2454.

PMID:
29063850
24.

The Prognostic Value of BRAF, C-KIT, and NRAS Mutations in Melanoma Patients With Brain Metastases.

Sperduto PW, Jiang W, Brown PD, Braunstein S, Sneed P, Wattson DA, Shih HA, Bangdiwala A, Shanley R, Lockney NA, Beal K, Lou E, Amatruda T, Sperduto WA, Kirkpatrick JP, Yeh N, Gaspar LE, Molitoris JK, Masucci L, Roberge D, Yu J, Chiang V, Mehta M.

Int J Radiat Oncol Biol Phys. 2017 Aug 1;98(5):1069-1077. doi: 10.1016/j.ijrobp.2017.03.030. Epub 2017 Mar 29.

PMID:
28721890
25.

Transplantation related toxicity and mortality in older autologous hematopoietic cell transplantation recipients.

Belete H, Burns LJ, Shanley R, Nayar M, McClune B, Lazaryan A, Bachanova V, Bejanyan N, Ustun C, Brunstein C, Weisdorf DJ, Arora M.

Am J Hematol. 2017 Sep;92(9):E529-E533. doi: 10.1002/ajh.24814. Epub 2017 Jul 19.

26.

Allogeneic hematopoietic cell transplantation in morphologic leukemia-free aplastic state.

Rashidi A, Ali AM, Vij KR, Shanley R, Romee R, Cooley SA, Westervelt P, DiPersio JF, Miller JS, Weisdorf DJ, Ustun C.

Am J Hematol. 2017 Sep;92(9):E549-E552. doi: 10.1002/ajh.24804. Epub 2017 Jul 19. Review. No abstract available.

27.

The Frequency of Carpal Tunnel Syndrome in Hurler Syndrome After Peritransplant Enzyme Replacement Therapy: A Retrospective Comparison.

Wyffels ML, Orchard PJ, Shanley RM, Miller WP, Van Heest AE.

J Hand Surg Am. 2017 Jul;42(7):573.e1-573.e8. doi: 10.1016/j.jhsa.2017.03.036. Epub 2017 May 4.

PMID:
28479223
28.

Neurocognitive Trajectory of Boys Who Received a Hematopoietic Stem Cell Transplant at an Early Stage of Childhood Cerebral Adrenoleukodystrophy.

Pierpont EI, Eisengart JB, Shanley R, Nascene D, Raymond GV, Shapiro EG, Ziegler RS, Orchard PJ, Miller WP.

JAMA Neurol. 2017 Jun 1;74(6):710-717. doi: 10.1001/jamaneurol.2017.0013.

29.

Pharmacogenetics of steroid-responsive acute graft-versus-host disease.

Arora M, Weisdorf DJ, Shanley RM, Thyagarajan B.

Clin Transplant. 2017 May;31(5). doi: 10.1111/ctr.12949. Epub 2017 Apr 4.

30.

Donor-to-Recipient ABO Mismatch Does Not Impact Outcomes of Allogeneic Hematopoietic Cell Transplantation Regardless of Graft Source.

Damodar S, Shanley R, MacMillan M, Ustun C, Weisdorf D.

Biol Blood Marrow Transplant. 2017 May;23(5):795-804. doi: 10.1016/j.bbmt.2017.02.009. Epub 2017 Feb 14.

31.

BEAM conditioning is well-tolerated and yields similar survival in obese and non-obese patients with lymphoma: no requirement for weight-based dose modifications.

Fair C, Shanley R, Rogosheske J, Lazaryan A, McClune B, Brunstein CG, Bachanova V.

Bone Marrow Transplant. 2017 Mar;52(3):491-493. doi: 10.1038/bmt.2016.316. Epub 2017 Jan 9. No abstract available.

32.

Use of dual-energy computed tomography to measure skeletal-wide marrow composition and cancellous bone mineral density.

Arentsen L, Hansen KE, Yagi M, Takahashi Y, Shanley R, McArthur A, Bolan P, Magome T, Yee D, Froelich J, Hui SK.

J Bone Miner Metab. 2017 Jul;35(4):428-436. doi: 10.1007/s00774-016-0796-1. Epub 2016 Dec 9.

33.

Estimating Survival in Patients With Lung Cancer and Brain Metastases: An Update of the Graded Prognostic Assessment for Lung Cancer Using Molecular Markers (Lung-molGPA).

Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP.

JAMA Oncol. 2017 Jun 1;3(6):827-831. doi: 10.1001/jamaoncol.2016.3834.

34.

The Effect of Gene Alterations and Tyrosine Kinase Inhibition on Survival and Cause of Death in Patients With Adenocarcinoma of the Lung and Brain Metastases.

Sperduto PW, Yang TJ, Beal K, Pan H, Brown PD, Bangdiwala A, Shanley R, Yeh N, Gaspar LE, Braunstein S, Sneed P, Boyle J, Kirkpatrick JP, Mak KS, Shih HA, Engelman A, Roberge D, Arvold ND, Alexander B, Awad MM, Contessa J, Chiang V, Hardie J, Ma D, Lou E, Sperduto W, Mehta MP.

Int J Radiat Oncol Biol Phys. 2016 Oct 1;96(2):406-413. doi: 10.1016/j.ijrobp.2016.06.006. Epub 2016 Jun 14.

35.

Impact of Graft-Recipient ABO Compatibility on Outcomes after Umbilical Cord Blood Transplant for Nonmalignant Disease.

Kudek MR, Shanley R, Zantek ND, McKenna DH, Smith AR, Miller WP.

Biol Blood Marrow Transplant. 2016 Nov;22(11):2019-2024. doi: 10.1016/j.bbmt.2016.07.019. Epub 2016 Aug 2.

36.

Umbilical cord blood transplantation is a suitable option for consolidation of acute myeloid leukemia with FLT3-ITD.

Eckfeldt CE, Randall N, Shanley RM, Yohe S, Bejanyan N, Dolan M, Warlick ED, Verneris MR, Brunstein CG, Wagner JE, Weisdorf DJ, Ustun C.

Haematologica. 2016 Aug;101(8):e348-51. doi: 10.3324/haematol.2016.143628. Epub 2016 Apr 28. No abstract available.

37.

Late Acute Graft-versus-Host Disease after Allogeneic Hematopoietic Stem Cell Transplantation.

Omer AK, Weisdorf DJ, Lazaryan A, Shanley R, Blazar BR, MacMillan ML, Brunstein C, Bejanyan N, Arora M.

Biol Blood Marrow Transplant. 2016 May;22(5):879-83. doi: 10.1016/j.bbmt.2015.12.020. Epub 2015 Dec 29.

38.

Blood transfusions and pulmonary complications after hematopoietic cell transplantation.

Solh M, Morgan S, McCullough J, Shanley R, Weisdorf DJ.

Transfusion. 2016 Mar;56(3):653-61. doi: 10.1111/trf.13415. Epub 2015 Dec 3.

39.

Particulate Air Pollution and Clinical Cardiovascular Disease Risk Factors.

Shanley RP, Hayes RB, Cromar KR, Ito K, Gordon T, Ahn J.

Epidemiology. 2016 Mar;27(2):291-8. doi: 10.1097/EDE.0000000000000426.

40.

Adjusting Cyclophosphamide Dose in Obese Patients with Lymphoma Is Safe and Yields Favorable Outcomes after Autologous Hematopoietic Cell Transplantation.

Bachanova V, Rogosheske J, Shanley R, Burns LJ, Smith SM, Weisdorf DJ, Brunstein CG.

Biol Blood Marrow Transplant. 2016 Mar;22(3):571-4. doi: 10.1016/j.bbmt.2015.10.012. Epub 2015 Oct 21.

41.

Intensity of MRI Gadolinium Enhancement in Cerebral Adrenoleukodystrophy: A Biomarker for Inflammation and Predictor of Outcome following Transplantation in Higher Risk Patients.

Miller WP, Mantovani LF, Muzic J, Rykken JB, Gawande RS, Lund TC, Shanley RM, Raymond GV, Orchard PJ, Nascene DR.

AJNR Am J Neuroradiol. 2016 Feb;37(2):367-72. doi: 10.3174/ajnr.A4500. Epub 2015 Oct 1.

42.

Ambient Particulate Matter Air Pollution Exposure and Mortality in the NIH-AARP Diet and Health Cohort.

Thurston GD, Ahn J, Cromar KR, Shao Y, Reynolds HR, Jerrett M, Lim CC, Shanley R, Park Y, Hayes RB.

Environ Health Perspect. 2016 Apr;124(4):484-90. doi: 10.1289/ehp.1509676. Epub 2015 Sep 15.

43.

Long-term outcomes after allogeneic hematopoietic stem cell transplantation for metachromatic leukodystrophy: the largest single-institution cohort report.

Boucher AA, Miller W, Shanley R, Ziegler R, Lund T, Raymond G, Orchard PJ.

Orphanet J Rare Dis. 2015 Aug 7;10:94. doi: 10.1186/s13023-015-0313-y.

44.

Longitudinal FDG-PET Revealed Regional Functional Heterogeneity of Bone Marrow, Site-Dependent Response to Treatment and Correlation with Hematological Parameters.

Yagi M, Froelich J, Arentsen L, Shanley R, Ghebre R, Yee D, Hui S.

J Cancer. 2015 Apr 15;6(6):531-7. doi: 10.7150/jca.11348. eCollection 2015.

45.

Cardiac QTc interval characteristics before and after hematopoietic stem cell transplantation: an analysis of 995 consecutive patients at a single center.

Miller WP, Shanley R, Dorostkar P.

Bone Marrow Transplant. 2015 Jul;50(7):954-60. doi: 10.1038/bmt.2015.64. Epub 2015 Mar 30.

46.

Development and validation of a clinical score for predicting risk of adenoma at screening colonoscopy.

Shaukat A, Church TR, Shanley R, Kauff ND, O'Brien MJ, Mills GM, Jordan PA, Allen JA, Kim A, Feld AD, Zauber AG, Winawer SJ.

Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):913-20. doi: 10.1158/1055-9965.EPI-14-1321. Epub 2015 Mar 23.

47.

Oncolytic adenovirus expressing interferon alpha in a syngeneic Syrian hamster model for the treatment of pancreatic cancer.

LaRocca CJ, Han J, Gavrikova T, Armstrong L, Oliveira AR, Shanley R, Vickers SM, Yamamoto M, Davydova J.

Surgery. 2015 May;157(5):888-98. doi: 10.1016/j.surg.2015.01.006. Epub 2015 Feb 27.

48.

Cytochrome P450 2B6*5 Increases Relapse after Cyclophosphamide-Containing Conditioning and Autologous Transplantation for Lymphoma.

Bachanova V, Shanley R, Malik F, Chauhan L, Lamba V, Weisdorf DJ, Burns LJ, Lamba JK.

Biol Blood Marrow Transplant. 2015 May;21(5):944-8. doi: 10.1016/j.bbmt.2015.02.001. Epub 2015 Feb 10.

49.

Angiotensin Converting Enzyme Inhibitors (ACEI) and doxorubicin pharmacokinetics in women receiving adjuvant breast cancer treatment.

Blaes A, Duprez D, Defor T, Shanley R, Beckwith H, Haddad T, Potter D, Yee D, Sanghavi K, Jacobson P.

Springerplus. 2015 Jan 23;4:32. doi: 10.1186/s40064-015-0802-4. eCollection 2015.

50.

Spatial and temporal fracture pattern in breast and gynecologic cancer survivors.

Hui SK, Arentsen L, Wilcox A, Shanley R, Yee D, Ghebre R.

J Cancer. 2015 Jan 1;6(1):66-9. doi: 10.7150/jca.10288. eCollection 2015.

Supplemental Content

Loading ...
Support Center